https://rjrindex.com/articles/clinicopathological-features-and-prognosis-of-med15-tfe3-rearrangement-renal-cell-carcinoma-an-upda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-active-surveillance-intensity-and-overtreatment-in-men-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanism-of-action-and-translation-to-the-clinic-of-detalimogene-voraplasmid-eg-70-a-novel-inve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-neutrophil-and-tumor-infiltrating-lymphocyte-count-and-bladder-cancer-stage-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-understanding-the-social-dimensions-of-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-cost-effectiveness-in-the-evolving-treatment-landscape-for-metastatic-urothelial-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-significance-of-prostate-specific-antigen-dynamics-during-abiraterone-therapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nsd2-inhibition-as-a-therapeutic-approach-for-treatment-induced-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-phase-ii-study-to-evaluate-olaparib-plus-abiraterone-and-prednisone-combination-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-analysis-of-circulating-tumor-cells-and-psma-imaging-metrics-to-predict-efficacy-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paraneoplastic-and-symptomatic-score-for-prediction-of-overall-and-cancer-specific-survival-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-experience-of-pneumonitis-in-patients-with-metastatic-renal-cell-carcinoma-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/absence-of-prostate-cancer-events-after-3-years-of-tailored-screening-in-high-risk-individuals-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ihsd3b1i-and-overall-survival-os-in-high-risk-non-metastatic-m0-and-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-perioperative-sacituzumab-govitecan-in-combination-with-zimberelimab-and-domvanalim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-mortality-risk-in-primary-penile-cancer-patients-a-retrospective-cohort-study-from-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-preoperative-fibrinogen-in-metastatic-clear-cell-renal-cell-carcinoma-patients-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characterization-and-treatment-patterns-in-patients-with-metastatic-hormone-sensitive-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-tandem-or-triplet-autologous-stem-cell-transplant-for-refractory-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-prognostic-value-of-cdk12-mutation-in-prostate-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-between-veterans-with-metastatic-castration-resistant-prostate-cancer-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-fgfr3-parg248cys-mutation-in-lynch-syndrome-associated-urothelial-carcinoma-a-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kim-1-as-a-circulating-biomarker-in-metastatic-rcc-post-hoc-analysis-of-javelin-renal-101 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-combined-chemotherapy-and-immunotherapy-for-upper-tract-urothelial-carcinoma-preliminar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-androgen-deprivation-therapy-and-acute-kidney-injury-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-psma-pet-results-at-biochemical-recurrence-bcr-with-metastasis-free-survival-mfs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-enfortumab-vedotin-and-pembrolizumab-for-patients-previously-treated-with-immune-checkpo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-after-brexucabtagene-autoleucel-administered-as-a-standard-therapy-for-adults-with-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-overall-survival-with-lutetium-lu-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-for-hepatocellular-carcinoma-an-expanding-cornerstone-of-care-in-the-era-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd39-expression-as-a-predictive-biomarker-for-neoadjuvant-treatment-in-muscle-invasive-bladder-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-clinical-impact-of-tumor-volume-on-response-to-sup177sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-specific-antigen-psa-response-in-black-patients-with-metastatic-castration-sensitive-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/access-to-immune-checkpoint-inhibitors-ici-in-patients-randomized-to-the-control-arm-of-ici-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-cystectomy-in-female-patients-does-the-urinary-diversion-type-affect-postoperative-complica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-patients-with-reduced-performance-status-ecog-2-or-higher-in-fda-registrational-trial-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-rspo2-activation-and-its-association-with-outcomes-and-potential-role-as-a-driver-in-doub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-patients-with-metastatic-renal-cell-carcinoma-with-or-without-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-patient-comparison-of-urinary-radioactivity-after-sup18sup-f-pifl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-health-related-quality-of-life-hrqol-assessment-and-immune-related-adverse-event-irae 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-patient-data-ipd-analysis-of-early-psa-nadir-in-arasens-latitude-and-titan-training 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-incidence-and-clinicopathologic-features-of-secondary-bladder-cancer-after-long-term 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-perioperative-acute-kidney-injury-on-future-renal-outcomes-in-patients-who-undergo-radical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-progression-following-systemic-and-tumor-directed-therapy-for-ide-novoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-physiological-monitoring-for-personalized-prediction-of-physical-function-and-fatigue-in-men 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-clinical-characterization-of-renal-cell-carcinoma-rcc-with-merlin-protein-deficienc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-burden-survival-tests-for-patients-with-metastatic-prostate-cancer-on-androgen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-urinary-cell-free-dna-methylation-assay-to-identify-tumor-fraction-for-early-detection-and-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-assessment-of-pre-and-post-covid-19-pandemic-nephrectomy-outcomes-for-renal-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-plus-ipilimumab-nivoipi-in-patients-with-metastatic-variant-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surveillance-with-plasma-ctdna-in-non-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-comparison-of-clinical-utility-between-pan-cancer-panel-and-pca-specific-panel-for-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-outcomes-of-sup177sup-lu-psma-617-in-patients-with-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nexus-01-a-phase-1-study-of-ly4052031-an-antibody-drug-conjugate-targeting-nectin-4-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/socioeconomic-position-as-a-social-determinant-of-health-and-its-effect-on-cardiovascular-outcomes-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peri-operative-treatment-patterns-in-real-world-muscle-invasive-bladder-cancer-patients-undergoing-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-urinary-cell-free-dna-fragmentomics-in-urothelial-carcinoma-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/octopus-a-retrospective-multicenter-study-of-real-world-cabozantinib-treatment-of-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-in-patients-pts-with-non-locally-pretreated-brain-metastases-bm-from-renal-cell-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-discontinuation-and-efficacy-data-of-abiraterone-acetateprednisone-aap-plus-androgen-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-patients-with-metastatic-hormone-sensitive-prostate-cancer-mhspc-benefit-more-from-androgen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-urothelial-carcinoma-in-england 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-between-protein-biomarkers-and-adverse-pathologic-features-in-mri-mapped-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-experience-with-emaco-chemotherapy-in-male-choriocarcinoma-a-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-psma-1007-petct-for-response-assessment-in-patients-with-metastatic-ren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-3-trial-of-docetaxel-added-to-adt-plus-arta-in-patients-with-metastatic-hormone-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-of-mibc-patients-not-receiving-radical-cystectomy-results-from-a-real-world-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-immune-checkpoint-inhibitor-rechallenge-in-metastatic-fumarate-hydratase-defi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fifteen-year-outcomes-of-external-radiation-with-or-without-6-months-of-neoadjuvant-deprivation-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-long-term-follow-up-from-a-phase-ii-clinical-trial-of-gemcitabine-and-cisplatin-as-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-deep-learning-algorithm-for-automated-p53-immunohistochemistry-digital-image-analysis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferred-treatment-regimens-for-rare-genitourinary-gu-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-variant-origin-prediction-vop-algorithm-to-distinguish-clonal-hematopoiesis-ch-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-signature-predictor-of-dose-response-to-prostate-radiation-validation-of-portos-in-phase-iii-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-gene-expression-signatures-of-immune-infiltration-on-response-to-sequential-intravesical-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-quality-of-life-in-prostate-cancer-patients-continuous-vs-intermittent-androgen-deprivat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-integrated-multi-omics-profiling-in-renal-cell-carcinoma-to-identify-molecular-subtypes-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-therapy-mdt-plus-androgen-deprivation-therapy-adt-for-oligometastatic-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-outcomes-of-patients-with-metastatic-non-clear-cell-renal-cell-carcinoma-mnccrcc-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-and-new-ctdna-analysis-in-met-driven-advanced-papillary-renal-cancer-calypso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-genitourinary-drug-approvals-by-the-fda-2020-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-mortality-trends-in-genitourinary-cancer-in-southeast-asia-from-1990-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-conventional-imaging-and-piflufolastat-f18-in-newly-diagnosed-and-recurrent-prostate-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-psa-based-igi-rate-and-conventional-psa-metrics-in-veter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chimeric-rna-landscape-in-the-chinese-population-and-the-role-of-isft2d2-tbx19i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-multi-parametric-mri-mpmri-compared-to-diagnostic-transurethral-resection-of-bladder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-safety-and-correlative-analysis-of-a-phase-ii-trial-in-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-treatment-of-metastatic-castration-resistant-prostate-cancer-patients-with-radium-223-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-first-line-1l-maintenance-therapy-in-advanced-urothelial-carcinoma-final-analysis-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lucarbo-a-phase-1a1b-trial-of-sup177sup-lu-psma-617-lupsma-with-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-initial-local-therapy-lt-in-the-combination-treatment-era-for-metastatic-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-baseline-and-changes-in-hemoglobin-levels-and-treatment-response-and-prognosis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-belzutifan-on-anemia-and-hypoxia-in-sporadic-and-ivhli-syndr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/s23psa-as-a-predictor-of-reclassification-of-1st-protocol-biopsy-on-active-surveillance-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-prospective-study-of-high-dose-testosterone-in-combination-with-carboplatin-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-enzalutamide-on-anticoagulant-therapy-with-edoxaban-in-patients-with-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-of-first-next-generation-sequencing-ngs-testing-at-the-end-of-life-in-patients-pts-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-and-on-treatment-ctdna-fraction-with-clinical-outcomes-in-patients-with-mcrp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survey-based-study-of-treatment-sequencing-after-first-line-1l-enfortumab-vedotinpembrolizumab-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-mcarh109-a-g-protein-coupled-receptor-class-c-group-5-member-d-gprc5d-targeted-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-renal-cell-cancer-histology-on-outcomes-of-microscopic-positive-surgical-margins-and-impli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-demographic-disparities-in-the-preferred-place-of-death-for-bladder-cancer-patients-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-of-spatial-transcriptomic-analyses-with-distance-associated-transcriptomic-spectrum-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypofractionated-radiotherapy-for-prostate-cancer-hydra-an-individual-patient-data-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kidney-sparing-approach-for-selected-localized-high-risk-upper-tract-urothelial-carcinoma-a-pilot-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-anti-pd-1-and-ctla-4-bispecific-antibody-combined-with-axitinib-for-the-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-specimen-type-on-digital-histopathology-based-multimodal-artificial-intelligence-mmai-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-clinicogenomic-study-of-androgen-receptor-mutations-and-co-mutations-in-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-y220c-mutations-in-advanced-urothelial-bladder-cancer-ubc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-proteomic-profiling-of-plasma-samples-associated-with-response-or-resistance-to-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-neoadjuvantinduction-nac-chemotherapy-in-nonmetastatic-muscle-invasive-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-practice-gaps-and-challenges-for-immunotherapy-integration-in-treatment-of-metastatic-urot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-intravesical-bacillus-calmette-guerin-instillation-for-superficial-recurrence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-androgen-deprivation-therapy-with-enzalutamide-plus-the-glucocorticoid-receptor-modulato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-tislelizumab-tisle-combined-with-pazopanib-in-reducing-venous-tumor-thrombu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-heterologous-prime-boost-strategy-using-ruti-vaccine-to-improve-the-bcg-response-in-non-muscle-inv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-clonal-hematopoiesis-and-survival-after-nephrectomy-in-patients-with-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perceptions-about-their-treatment-for-muscle-invasive-bladder-cancer-mibc-over-the-last-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-systemic-therapy-and-surgical-consolidation-in-patients-with-node-positive-upper-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/additivity-and-the-efficacy-of-immune-checkpoint-blockade-based-combination-regimens-in-urothelial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-ex-vivo-platform-to-model-immunotherapy-in-kidney-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-sociodemographic-marginalization-and-receipt-of-intensified-treatment-for-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bladder-preservation-therapy-for-very-high-risk-non-muscle-invasive-bladder-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-access-program-of-cretostimogene-grenadenorepvec-in-patients-with-non-muscle-invasive-bladd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-cabozantinib-nc-vs-sunitinib-s-for-previously-untreated-advanced-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pam50-for-predicting-progression-in-active-surveillance-results-from-the-miami-mast-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-clinical-and-pathologic-staging-of-t2a-b-and-t3a-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-ecog-performance-status-ps-using-large-language-models-in-patients-with-advanced-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-role-of-circulating-tumor-dna-ctdna-clearance-as-a-biomarker-in-localized-and-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-patients-diagnosed-with-metastatic-castration-resistant-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opar-a-randomized-trial-of-partial-breast-irradiation-in-five-fractions-once-daily-for-early-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-practice-gaps-in-timely-homologous-recombination-repair-gene-mutation-hrrm-tes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-medicare-advantage-ma-on-timely-hormonal-intensification-in-metastatic-hormone-sensitive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-us-county-level-analysis-of-erectile-dysfunction-diagnosis-following-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-from-a-prospective-study-of-comprehensive-genomic-testing-in-patients-pts-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-window-of-opportunity-study-of-ultrasound-guided-long-acting-periprostatic-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-concomitant-squamous-differentiation-in-upper-tract-urothelial-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitive-tissue-based-detection-of-ar-v7-and-other-androgen-receptor-alterations-using-combined-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastasis-directed-treatment-mdt-for-patients-pts-with-non-clear-cell-renal-cell-carcinoma-ncc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-optimal-patient-selection-for-high-intensity-focused-ultrasound-hifu-for-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-integrating-palliative-care-on-the-uptake-of-advance-care-planning-among-elderly-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-variables-and-risk-factors-associated-with-urinary-leak-following-partial-nephrectomy-insi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-the-activity-of-inflammasome-genes-and-their-association-with-oncological-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-extended-interval-dosing-of-denosumab-in-patients-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-investigation-of-cpsf3s-role-in-the-progression-of-bladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-clinical-outcomes-of-first-line-treatment-in-metastatic-papillary-renal-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-hypofractionated-radiotherapy-and-pembrolizumab-in-the-treatment-of-muscle-invasive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ngs-based-molecular-panel-analysis-of-metastatic-prostate-cancer-for-daily-routine-how-often-do-we 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-survival-in-aggressive-variant-prostate-cancer-patients-undergoing-psma-radioligand-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-monotherapy-in-patients-with-castration-sensitive-prostate-cancer-cspc-after-biochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-pelvic-radiotherapy-on-hematological-outcomes-in-pediatric-genitourinary-rhabdomyosarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-undetectable-psa-nadir-and-outcomes-for-patients-with-metastatic-hormone-sensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-pten-loss-on-outcomes-in-high-very-high-risk-advanced-hormone-sensitive-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fexagratinib-fexa-in-combination-with-tislelizumab-t-in-a-phase-ii-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subdue-3-sub-urothelial-durvalumab-sirconium-to-investigate-local-and-systemic-distribution-of-durv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rad-sg-adaptive-radiation-therapy-with-concurrent-sacituzumab-govitecan-sg-for-bladder-preservati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-single-vs-combination-therapy-on-survival-outcomes-in-mhspc-patients-strat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/world-wide-oligometastatic-prostate-cancer-ompc-meta-analysis-leveraging-individual-patient-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-of-non-clear-cell-and-clear-cell-renal-cell-carcinomas-with-indication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-follow-up-of-prostate-specific-membrane-antigen-petct-guided-salvage-radiotherapy-followi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-racial-disparities-in-testicular-cancer-survival-evidence-from-a-nationwide-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-diversity-and-disparities-in-a-real-world-locally-advancedmetastatic-urothelial-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progressive-t-cell-exhaustion-and-predominance-of-aging-tissue-associated-macrophages-with-advancing-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-efficacy-and-safety-exposure-response-er-analysis-of-tivozanib-tivo-for-the-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-analysis-of-tumor-tissue-from-patients-with-metastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-upstaging-from-ct2a-b-to-pt3a-on-overall-survival-os-among-patients-with-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reflexive-paired-somatic-and-germline-testing-at-time-of-medical-oncology-referral-in-mcspc-impact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-diabetes-mellitus-on-acute-care-use-in-older-patients-with-metastatic-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ifgd1i-splice-variants-as-predictors-of-brain-and-bone-metastatic-organotropism-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-site-of-metastatic-involvement-on-imdc-classification-in-metastatic-renal-cell-carcinoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-treatment-selection-for-medicare-beneficiaries-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ev-302-updated-analysis-from-the-phase-3-global-study-of-enfortumab-vedotin-in-combination-with-pem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-adherence-to-a-remote-exercise-program-on-health-related-quality-of-life-in-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protein-analysis-of-urachal-carcinoma-tissue-based-on-different-antibody-drug-conjugate-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-of-jak-inhibition-in-stem-like-prostate-cancer-jasper-a-phase-12-multicenter-study-of-ruxo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/datopotamab-deruxtecan-dato-dxd-in-locally-advancedmetastatic-urothelial-cancer-updated-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-prognosis-of-metastatic-non-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-demographics-and-outcomes-in-hospitalized-patients-with-young-versus-averag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-tumor-microenvironmental-features-of-primary-and-synchronous-liver-metastases-from-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-y220c-mutations-in-pancreatic-ductal-adenocarcinoma-pdac-a-genomic-landsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-tu-100-on-hepatocarcinogenesis-and-colorectal-liver-metastasis-in-mash-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-her2-gene-dosage-and-heterogeneity-at-a-single-cell-resolution-in-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-pd-l1-expression-and-the-number-of-biopsy-specimens-in-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multimodal-deep-learning-approach-for-the-prognostic-stratification-of-patients-with-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-characteristics-of-tislelizumab-tis-plus-chemotherapy-chemo-in-first-line-1l-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-circulating-tumor-dna-for-locally-advanced-esophageal-squamous-cell-carcinoma-bef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pkpd-analyses-of-circulating-tumor-dna-ctdna-in-patients-with-metastatic-colorectal-cancer-mcrc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-of-trastuzumab-deruxtecan-with-gastric-cancer-all-patient-post-marketing-surveill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-and-first-line-treatment-patterns-among-locally-advanced-unresectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-line-therapy-with-nal-iri5-fufa-after-failure-of-gemcitabinenab-paclitaxel-in-advanced-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-hepatocellular-carcinoma-cholangiocarcinoma-insights-from-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-the-paradigm-early-identification-of-colorectal-cancer-with-c-the-signs-clinical-decision 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-comparative-study-on-mdt-practices-in-the-management-of-hepatocellular-carcinoma-in-high-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-clinical-trial-enrollment-among-lgbtq-individuals-and-its-impact-on-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitizing-k-ras-g12d-mutant-colorectal-patient-derived-organoids-via-ferroptosis-pathway 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-with-or-without-chemotherapy-in-right-sided-metastatic-colorectal-cancer-updated-result 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-cycle-neoadjuvant-pembrolizumab-in-patients-with-stage-i-iii-mmr-deficient-colon-cancer-fina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-point-surrogacy-in-first-line-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-double-window-of-opportunity-trial-evaluating-the-oral-tgf-beta-receptor-i-inhibitor-vact 2026-08-24 monthly 0.7 https://rjrindex.com/articles/herizon-btc-302-a-phase-3-study-of-zanidatamab-with-standard-of-care-soc-therapy-vs-soc-alone-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-combining-pd-l1-and-ctla-4-blockade-with-transarterial-chemoembolization-in-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-marital-status-and-race-on-survival-of-patients-with-well-differentiated-neuroendocrine-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-peri-operative-chemotherapy-and-radiation-use-among-patients-with-resected-pancreatic-duc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-trifluridine-tipiracil-monotherapy-ftd-tpi-and-ftd-tpi-bevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-matched-tumor-samples-in-patients-with-rectal-cancer-undergoing-total-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/robot-assisted-esophagectomy-with-extended-mediastinal-lymph-node-dissection-the-learning-curve-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unbiased-transcriptomic-analysis-of-primary-early-onset-vs-late-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gut-and-mucosal-microbiomes-in-patients-with-extrahepatic-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-agent-797-invariant-natural-killer-t-cells-botensilimab-fc-enhanced-ctla-4-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uses-of-vegf-inhibitor-bevacizumab-in-appendiceal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-phase-iiiii-randomized-controlled-trials-rcts-to-evaluate-the-incidence-of-hand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-clinical-trial-of-preoperative-docetaxeloxaliplatins-1-dos-combination-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vascular-endothelial-growth-factor-receptor-vegfr-tyrosine-kinase-inhibitors-combined-with-progra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-associated-with-recurrence-after-salvage-surgery-for-localized-anal-cancer-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-barriers-in-germline-testing-among-patients-with-early-onset-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-metastatic-colorectal-cancer-crc-using-comprehensive-circulating-tumor-dna-ctdna-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-for-msi-h-colorectal-cancer-with-isolated-peritoneal-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-an-individualized-neoantigen-targeting-immunotherapy-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-survival-outcomes-in-patients-with-early-vs-late-onset-colorectal-cancer-with-liver-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-the-impact-of-timing-of-biomarker-testing-on-first-line-treatment-choice-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-autologous-cd8-and-cd4-transgenic-t-cells-expressing-high-affinity-kras-g12v-muta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-a-blood-based-test-for-colorectal-cancer-screening-adjusted-to-the-us-census-age-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-risk-factors-treatment-strategy-and-outcomes-of-early-vs-older-onset-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-for-locally-advancedmetastatic-mismatch-repair-deficient-colorectal-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-nectin-4-expression-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1-inhibitor-sintilimab-and-fruquintinib-plus-sox-as-conversion-therapy-for-initially-unresectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-peritoneal-limited-metastatic-gastric-cancer-plgc-undergoing-bidirection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-response-in-patients-with-gastricgastroesophageal-junction-adenocarcinoma-gea-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-in-patients-with-newly-diagnosed-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-plus-tremelimumab-for-unresectable-hepatocellular-carcinoma-in-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fruquintinib-alternating-with-bevacizumab-plus-capecitabine-as-maintenance-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implication-of-the-novel-microtubule-targeting-agent-aus-001-in-pancreatic-cancer-cellular-signali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/op-tnt-phase-ii-study-of-total-neoadjuvant-chemoradiotherapy-followed-by-local-resection-for-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sirtuin-genes-expression-on-first-line-treatment-outcomes-in-patients-pts-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-education-on-clinical-confidence-utilizing-her2-targeted-therapies-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-anamorelin-in-gastrointestinal-cancer-with-cancer-cachexia-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-simultaneous-adaptive-mri-guided-liver-sbrt-in-patients-with-heavily-pretreated-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-t3-and-t4-colon-cancer-is-there-a-promising-future 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-folfoxiri-for-high-risk-relapsed-locally-advanced-colon-cancer-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-mdm2-amplification-and-survival-among-patients-with-advanced-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mesothelin-msln-expression-measured-by-rna-sequencing-rnaseq-and-immunohistochemi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-event-free-survival-efs-as-a-surrogate-for-overall-survival-os-in-patients-with-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-utilization-of-colorectal-cancer-screening-modalities-among-patients-with-average-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bifunctional-anti-pd-l1tgf-vrii-agent-shr-1701-plus-chemotherapy-as-first-line-treatment-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-burden-of-hepatocellular-carcinoma-recurrence-after-curative-treatment-in-spain 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-double-blind-phase-iii-study-comparing-trifluridinetipiracil-ftdtpi-versus-placeb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-study-investigating-rp2-oncolytic-immunotherapy-in-combination-with-second 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-neoadjuvant-radiation-therapy-modalities-on-post-surgical-lymphopenia-in-operable-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-palliative-care-utilization-among-patients-with-anal-cancer-a-ten-year-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leading-the-way-how-leading-chinese-institutions-drive-mdt-excellence-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-factors-for-the-efficacy-of-nal-iri-5fulv-therapy-in-patients-previously-treated-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-novel-biomarkers-and-novel-therapies-for-immune-checkpoint-inhibitors-icis-in-genet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-protein-energy-malnutrition-on-outcomes-in-patients-with-cholangiocarcinoma-admitted-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-patients-with-advanced-gastrointestinal-stromal-tumor-in-japan-an-administrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cross-sectional-analysis-from-a-real-world-cohort-of-patients-with-microsatellite-instability-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-plus-anlotinib-followed-by-surgery-for-locally-advanced-esophageal-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-risk-of-cardiovascular-events-among-gastroesophageal-cancer-patients-receiving-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-sintilimab-in-cancer-of-unknown-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-expand-indication-of-her2-targeted-therapies-by-monitoring-of-circulating-tumor-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-cut-off-value-for-lymph-node-harvesting-in-colon-cancer-based-on-tumor-stage-and-sidedness 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bragg-peak-proton-irradiation-and-atm-inhibition-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rate-of-gene-fusionrearrangement-identification-in-gi-cancers-as-sequencing-evolved-from-limited-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-nurses-telephone-follow-up-program-tsukiji-call-for-resectable-locally-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-small-bowel-adenocarcinoma-sba-from-2000-2019-in-the-united-state 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-nutritional-status-on-recurrence-free-survival-rfs-in-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-atezolizumab-plus-bevacizumab-treatment-in-patients-with-advanced-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-treatment-in-patients-with-advanced-gastrointestinal-stromal-tumours-gists-in-second-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-nivo-chemotherapy-chemo-vs-chemo-as-first-line-1l-treatment-for-advanced-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-cachexia-and-anti-cancer-therapies-on-gdf-15-levels-in-patients-with-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-clinical-trial-evaluating-the-safety-and-efficacy-of-initial-dose-adjustment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gastric-cancer-patient-insights-patient-reported-outcomes-and-real-world-perspectives-from-the-gast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-pandemic-on-critically-ill-patients-with-colon-cancer-a-population-level-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-blood-based-colorectal-cancer-screening-a-simulation-model-incorporating-real 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lenvatinib-plus-hepatic-arterial-infusion-chemotherapy-of-oxaliplatin-fluorouracil-and-leucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-organ-preservation-op-in-node-negative-nn-low-rectal-cancer-rc-updated-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-screening-outcomes-associated-with-advanced-precancerous-lesion-versus-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-amplitude-modulated-radiofrequency-electromagnetic-fields-am-rf-emf-in-metastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-study-of-esophago-gastric-adenocarcinoma-egac-in-young-patients-under-the-age-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-deep-learning-based-pathomics-signature-for-prognosis-and-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-overall-survival-os-benefit-be-predicted-from-improvements-in-progression-free-survival-pfs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-radiomics-model-for-preoperative-pancreatic-neuroendocrine-tumor-grade-prediction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-emtansine-as-second-line-therapy-in-her2-positive-advanced-biliary-tract-cancers-single 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-engagement-in-pancreatic-adenocarcinoma-provisional-results-of-ilsta-study-durvaluma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/update-of-phase-1b2-study-of-muzastotug-adg126-an-anti-ctla-4-safebody-in-combination-with-pembr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-mfolfirinox-efficacy-as-first-and-subsequent-lines-of-advanced-gastrointestinal-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-racial-disparities-in-hepatocellular-carcinoma-associated-with-metabolic-syndro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-the-optimal-post-surgical-timing-of-molecular-residual-disease-mrd-detection-in-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-clinically-actionable-alterations-in-baseline-tumor-versus-plasma-samples-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-right-versus-left-sided-colon-cancer-and-rectal-cancer-in-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-khorana-score-2-molecular-correlates-of-venous-thromboembolism-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/5-hydroxymethylcytosine-as-a-liquid-biopsy-biomarker-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ugt1a1-mutation-rates-in-a-minority-rich-comprehensive-cancer-center-a-retrospective-pharmacogenomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ww-vs-tme-in-patients-with-rectal-cancer-with-a-complete-or-near-complete-response-to-tnt-pooled-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-outcomes-in-dmmrmsi-h-andor-tmb-h-metastatic-colorectal-cancer-crc-with-peritoneal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-the-colorectal-cancer-alliances-digital-screening-quiz-and-navigation-model-for-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bxq-350-a-novel-sphingolipid-metabolism-modulator-in-combination-with-mfolfox7-and-bevacizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-value-and-indications-for-surgery-in-pancreatic-cancer-with-synchronous-liver-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-the-association-of-ictrb2i-exon-6-deletion-with-time-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-of-tas-102-combined-with-intermittent-administration-of-fruquintinib-in-the-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-differences-in-colorectal-cancer-across-race-and-ethnicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-neighborhood-deprivation-index-on-survival-in-gastric-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-locoregional-therapies-and-immune-checkpoint-inhibitor-ici-for-treating 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatially-resolved-protein-profiling-in-pancreatic-adenosquamous-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-imbalance-in-colon-cancer-screening-rates-in-texas-a-population-based-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-characteristics-of-patients-with-brain-metastases-at-diagnosis-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mediation-of-the-liver-protective-effect-of-the-anti-cancer-drug-candidate-namodenoson-via-adiponect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surufatinib-combined-with-tas-102-as-a-late-line-therapy-in-patients-with-metastatic-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-child-pugh-scores-and-outcomes-of-patients-with-hepatocellular-carcinoma-at-a-high-volume 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-versus-single-immune-checkpoint-blockade-for-patients-with-metastatic-colorectal-cancer-harbori 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-toxicities-and-survival-outcomes-among-patients-with-stage-iii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-mediastinal-lymph-node-positivity-in-patients-undergoing-robotic-transthoracic-esophage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-sequences-in-patients-with-metastatic-colorectal-cancer-in-japan-real-world-evidence-of-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-treatment-delivery-of-perioperative-flot-therapy-in-locally-advanced-oga-associated-with-recurren 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-plogosertib-cyc149462-a-novel-orally-bioavailable-plk1-inhibitor-on-patient-derived 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-circulating-tumor-dna-in-patients-with-unresectable-pancreatic-cancer-using-a-patient-spe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-financial-burden-among-patients-with-pancreatic-cancer-at-a-tertia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-plasma-circulating-tumor-dna-assay-using-highly-sensitive-safe-seqs-technolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-imaging-and-machine-learning-based-radiomics-for-detection-of-mixed-hcc-and-cca-tumors-still-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-unmet-needs-in-colorectal-cancer-insights-from-patient-and-survivor-experiences 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-incidence-of-oncogenic-irasi-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-tumor-regression-grade-trg-in-patients-with-gastricgastroesophageal-junction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-retrospective-observational-study-of-outcomes-of-treatment-for-unresectable-neuroendoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-impact-of-postoperative-outcomes-and-quality-of-life-on-decisional-regret-after-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-baseline-alterations-in-her2-pathway-oncogenic-drivers-on-response-to-anti-her2-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-study-of-dosage-strategies-in-hipec-bsa-based-vs-fixed-dose-methods 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-depression-on-esophageal-cancer-outcomes-using-the-national-inpatient-sample-nis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-ivaltinostat-an-hdac-inhibitor-plus-capecitabine-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-metastatic-spread-and-survival-outcomes-for-stage-iv-left-sided-colon-vs-rectal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-novel-therapies-and-circulating-tumor-dna-ctdna-as-a-marker-of-response-in-curatively-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-gi-cancer-leading-change-to-meet-the-needs-of-the-gastrointestinal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-in-gene-amplification-between-ierbb2i-and-other-oncogenes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-stereotactic-body-radiation-therapy-to-the-liver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-course-chemoradiation-vs-short-course-radiation-in-total-neoadjuvant-therapy-for-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-in-circulating-tumor-dna-ctdna-and-response-to-telisotuzumab-adizutecan-abbv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retreatment-with-immune-checkpoint-inhibitors-icis-for-patients-with-advanced-gastric-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-landscape-of-fgfr-variations-and-prognosis-revelance-in-colorectal-cancer-from-circula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-study-of-afatinib-with-capecitabine-in-patients-with-refractory-solid-tumors-and-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-immune-checkpoint-inhibitor-utilization-and-pd-l1-testing-in-advanced-gastroesophageal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-2-trial-of-ramucirumab-plus-docetaxel-as-second-line-treatment-for-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-ctdna-monitoring-to-assess-the-recurrence-of-early-stage-pancreatic-cancer-after-surger 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-circulating-tumor-dna-ctdna-testing-in-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-xtx101-a-tumor-activated-fc-enhanced-anti-ctla-4-monoclonal-antibody-in-combin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-niraparib-and-dostarlimab-for-the-treatment-of-germline-or-somatic-homologous-reco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-immunotherapy-in-metastatic-pancreatic-carcinoma-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomics-based-prediction-of-hcc-response-to-atezolizumabbevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathologic-response-of-phase-iii-study-perioperative-camrelizumab-plus-rivoceranib-and-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-renin-angiotensin-system-inhibitors-on-patients-with-pancreatic-cancer-receiving-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefits-of-adjuvant-chemotherapy-after-surgical-resection-of-para-aortic-lymph-node-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-phase-ii-trial-of-second-line-aflibercept-plus-folfiri-in-patients-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-repertoire-sequencing-analysis-to-detect-differences-in-treatment-responses-for-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-path-study-adjuvant-therapy-with-donafenib-plus-a-pd-1-inhibitor-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-anti-egfr-therapy-across-different-lines-of-treatment-in-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tislelizumab-chemotherapy-versus-placebo-chemotherapy-on-patient-reported-symptoms-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-shr-1701-on-chemotherapy-chemo-induced-myelosuppression-data-from-a-phase-3-study-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-differences-in-advanced-biliary-tract-cancer-patients-with-ctdna-detected-idh1-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-machine-learning-model-for-mortality-after-curative-gastrectomy-for-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ql1203-vs-placebo-plus-mfolfox6-as-first-line-therapy-in-ras-wild-type-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrutinib-in-early-stage-chronic-lymphocytic-leukemia-the-randomized-placebo-controlled-double-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hormonal-contraception-and-breast-cancer-risk-for-carriers-of-germline-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-of-the-impact-of-artificial-intelligence-in-pancreatic-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/organ-specific-responses-to-nivolumab-plus-ipilimumab-in-patients-with-advanced-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-randomized-controlled-trials-rcts-to-evaluate-the-incidence-of-hemorrhage-and-ven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-real-world-outcomes-of-single-versus-multi-agent-preoperative-chemoradiotherapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-dose-intensity-di-and-time-to-adverse-events-aes-in-a-commercial-database-during-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kras-status-in-lung-oligometastases-treated-with-sbrt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/annual-incidence-of-colorectal-cancer-among-patients-with-average-risk-in-the-united-states-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomics-and-lethality-associated-stromal-remodeling-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-relapse-free-survival-in-stage-iii-gastric-cancer-patients-treated-with-postoperative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trifluridinetipiracil-and-bevacizumab-ftdtpibev-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-is-the-optimal-treatment-strategy-of-salvage-line-treatment-after-progression-on-anti-epidermal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-nalirifox-compared-to-other-first-line-treatments-for-metastatic-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalationexpansion-study-of-gsk5764227-gsk227-a-b7-homolog-3-b7-h3-protein-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-and-meta-analysis-on-evaluating-the-efficacy-and-safety-of-netupitantpalonosetr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd8-supsup-t-cell-proximity-analysis-of-the-tumor-microenvironment-tm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-serum-and-urine-mirnas-as-biomarkers-of-cancer-cachexia-in-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-early-onset-colorectal-cancer-related-mortality-among-adults-in-the-united-states-from-199 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparison-of-real-world-outcomes-by-mismatch-repair-status-in-patients-with-stage-iiiii-rectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-folfiri-with-low-dose-irinotecan-plus-ramucirumab-as-second-line-treatment-in-japa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implication-of-body-composition-changes-in-patients-with-borderline-resectablelocally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-therapy-with-somatostatin-analogs-for-recurrent-gastric-neuroendocrine-tumors-type-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-infusion-chemotherapy-and-embolization-taice-as-a-pre-operative-therapy-for-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ii-trial-of-systemic-chemotherapy-with-or-without-trastuzumab-followed-by-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-duration-of-neoadjuvant-chemotherapy-prior-to-crshipec-for-colorectal-cancer-an-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/provider-perspectives-on-non-medical-barriers-to-gi-cancer-care-at-a-regional-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-unplanned-readmission-to-the-same-facility-within-30-days-following-robot-assisted-and-lap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aflibercept-afl-vs-ramucirumab-ram-based-therapy-in-patients-with-advanced-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-role-of-circulating-tumor-dna-ctdna-in-stage-iii-colon-cancer-treated-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-transarterial-chemoembolization-plus-atezolizumab-and-bevacizumab-in-unresectable-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-differences-in-the-colorectal-tumor-immune-microenvironment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-nivolumab-nivo-plus-ipilimumab-ipi-vs-nivo-monotherapy-for-microsatellite-insta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digesting-danger-a-two-decade-study-exploring-the-association-between-food-processing-and-colon-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-qualitative-study-of-the-home-based-time-burdens-faced-by-persons-affected-by-gi-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ib-study-of-gevokizumab-gevo-in-combination-with-standard-of-care-soc-anticancer-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-modified-m-folfoxiri-plus-cetuximab-versus-bevacizumab-for-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-immunotherapy-trials-network-12-pembrolizumab-in-hiv-associated-kaposi-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-radiological-progression-in-participants-pts-with-embolization-eligible-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-regulatory-approval-of-a-new-systemic-targeted-therapy-for-advanced-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-pd-l1-assays-28-8-and-sp263-and-their-respective-scoring-algorithms-in-procured 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-haip-therapy-in-metastatic-colorectal-cancer-efficacy-safety-and-progno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-her2-targeted-therapies-in-biliary-tract-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-preoperative-lynch-syndrome-diagnosis-on-surgery-in-patients-with-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pattern-and-predictors-of-d3-lymph-node-station-positivity-in-patients-undergoing-curative-surgery-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-her2-agents-in-the-treatment-of-biliary-tract-cancers-a-systematic-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-durvalumab-d-with-or-without-tremelimumab-t-in-routine-clinical-practice-according-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ibii-study-of-fruquintinib-plus-5-fluorouracilleucovorin-after-progression-on-fruquintinib-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-and-nonoperative-management-of-dmmr-gastroesophageal-adenocarcinoma-gea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-the-role-of-oncogenic-iher2i-variants-as-drivers-of-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-alter-h006-a-phase-ii-study-of-benmelstobart-pd-l1-inhibitor-plus-anlotinib-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-gender-and-socioeconomic-disparities-in-survival-outcomes-of-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toxicology-and-clinical-protocol-development-of-duo-207-an-ultrasmall-nanomedicine-co-delivering-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-modulation-of-sorafenib-sor-induced-autophagy-using-hydroxychloroquine-hcq-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-trial-of-olaparib-pembrolizumab-vs-olaparib-alone-as-maintenance-therapy-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-social-support-discrimination-and-perceived-health-in-patients-with-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-phase-2-study-of-atezolizumab-plus-bevacizumab-atezobev-combination-therapy-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hlx22-plus-trastuzumab-and-xelox-for-first-line-treatment-of-her2-positive-locally-advanced-or-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-powered-analysis-of-tumor-infiltrating-lymphocytes-tils-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-patient-data-ipd-pooled-analysis-on-the-optimal-therapeutic-management-of-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clarity-gastric-01-a-randomized-phase-3-study-of-azd0901-a-claudin182-cldn182-targeted-antibod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-baseline-geriatric-and-quality-of-life-assessments-on-treatment-outcomes-in-ecog-acrin-ea2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-and-phase-12-data-of-the-chk1-inhibitor-bbi-355-in-development-for-esophageal-and-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folfiri-ramucirumab-folfiri-ram-versus-ramucirumab-paclitaxel-ram-pac-in-the-second-line-2l-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-microsatellite-instability-testing-using-a-multiplex-assay-including-long-mononucleotide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-mrp4-levels-on-clinical-outcomes-in-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iia-clinical-trial-of-first-line-cyclical-therapy-alternating-gemcitabine-cisplatin-and-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-oncogenomic-analysis-of-metastatic-squamous-cell-carcinoma-of-the-anus-utilizing-whole 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-liver-cancer-risk-and-outcomes-in-the-lgbtq-community-a-literature-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-management-of-locally-advanced-rectal-cancer-with-total-neoadjuvant-therapy-in-an-unders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatotoxicity-following-external-radiotherapy-in-patients-with-hepatocellular-carcinoma-treated-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-of-durvalumab-plus-gemcitabine-and-cisplatin-in-patients-with-advanced-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-liquid-biomarker-analysis-from-the-neonax-trial-for-response-prediction-to-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-demographics-mortality-outcomes-and-resource-utilization-in-early-onset-versus-later 2026-08-24 monthly 0.7 https://rjrindex.com/articles/focusing-on-clinical-trial-ineligibility-nivolumab-plus-chemotherapy-for-patients-with-advanced-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-signet-ring-cell-src-gastric-carcinoma-gc-compared-with-other-histological-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-treatment-handling-and-compliance-on-overall-response-rate-in-a-phase-iii-study-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telotristat-ethyl-to-promote-weight-stability-in-patients-with-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-centered-adverse-event-reporting-in-clinical-trials-a-novel-approach-using-ecog-acrin-e2211 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-treatment-patterns-among-patients-pts-with-metastatic-colorectal-cancer-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-1a-dose-escalation-study-of-bgb-b167-a-cea-x-4-1bb-bispecific-antibody-as-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-fog-001-a-first-in-class-direct-v-catenintcf-inhibitor-in-patients-with-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-defactinib-in-combination-with-avutometinib-in-patients-with-advanced-diffuse-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-tislelizumab-tis-plus-chemotherapy-ct-vs-placebo-pbo-plus-ct-in-advancedmetas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-folinic-acid-fluorouracil-oxaliplatin-bevacizumab-botensilimab-balstilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-liquid-biopsy-comprehensive-genomic-profiling-to-identify-the-molecular-landscape-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unraveling-the-role-of-interferon-stimulated-neutrophils-a-promising-biomarker-for-immunotherapy-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-nivolumab-nivo-plus-chemotherapy-chemo-vs-chemo-in-patients-pts-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adagrasib-ada-cetuximab-cetux-for-ikrasi-supg12csup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-and-therapeutic-response-in-gnas-mutated-colorectal-adenocarcinoma-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemoradiation-combined-with-immunotherapy-for-patients-with-high-risk-resectable-extrahepa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-receipt-of-guideline-concordant-pancreatic-cancer-care-among-older-adults-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insight-a-phase-3-randomized-open-label-study-of-ripretinib-vs-sunitinib-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-factors-related-to-survival-in-gastroenteropancreatic-neuroendocrine-tumors-gep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-prophylactic-tetracycline-use-among-patients-with-metastatic-colorectal-cancer-underg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trajectories-of-premorbid-healthcare-contact-days-in-veterans-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-pathogenic-variants-in-a-cohort-of-individuals-with-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pancreatic-tumour-biomechanics-on-diagnosis-and-post-operative-complications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-laurens-subtype-in-locally-advanced-gastric-cancer-lagc-prognosis-a-call-for-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mutational-landscape-in-primary-and-metastatic-pancreatic-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-frailty-risk-assessment-in-long-term-survivors-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-intrathecal-targeted-drug-delivery-itdd-on-oral-morphine-equivalents-and-pain-scores-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-isdc2i-gene-in-conjunction-with-iseptin9 2026-08-24 monthly 0.7 https://rjrindex.com/articles/btn1a1-expression-in-colon-cancer-implications-for-immunotherapy-and-patient-stratification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-nanoliposomal-irinotecan-and-fluorouracil-with-folinic-acid-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tislelizumab-chemotherapy-versus-placebo-chemotherapy-on-patient-reported-symptoms-and-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-cost-of-care-of-immune-oncology-treatments-for-unresectable-hepatocellular-carcinoma-a-singap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-perioperative-chemotherapy-combined-with-pd-1-inhibitor-versus-chemotherapy-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-immune-cell-abundance-across-hepatocellular-carcinoma-disease-stages-i-iii-findings-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-11b-dose-expansion-results-of-the-bifunctional-egfrtgfv-inhibitor-ficerafusp-alf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-mid-chemoradiation-ctdna-results-and-clinical-complete-response-to-total-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-scrt-followed-by-fruquintinib-plus-adebrelimab-and-capox-in-the-total-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-aes-derived-biomarker-in-predicting-clinical-outcomes-in-patients-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-the-northstar-response-a-novel-quantitative-methylation-ctdna-monitoring-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-matched-targeted-therapy-on-survival-in-advanced-biliary-tract-cancer-an-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analysis-of-paired-primary-and-metastatic-pancreatic-ductal-adenocarcinoma-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-biomarker-assessment-of-st316-a-novel-peptide-antagonist-of-ss-catenin-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-a-randomized-open-label-phase-2-study-of-botensilimab-bot-with-or-witho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-botensilimab-bot-plus-balstilimab-bal-in-resectable-mismatch-repair-proficient-pmmr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-upfront-folfoxiri-and-bevacizumab-with-cadonilimab-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-malignant-portal-vein-thrombosis-in-patients-with-pancreatic-cancer-a-retrospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-novel-gene-fusions-in-gastrointestinal-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-study-to-assess-colonic-microbiome-changes-in-response-to-energy-drink-consumption-rosan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-comparison-of-second-line-treatment-strategies-for-patients-with-rasraf-wild-ty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-surveillance-in-patients-with-intraductal-papillary-mucinous-neoplasms-ipmns-who-teste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-preferences-in-advanced-pancreatic-ductal-adenocarcinoma-pdac-from-qualitative-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-contrast-mri-as-a-surveillance-tool-for-recurrent-hepatocellular-carcinoma-after-curative-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-organ-preservation-rate-for-high-risk-stage-i-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-vascularity-as-a-predictor-of-fgfr-inhibitor-response-in-fgfr2-fused-intrahepatic-cholangiocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-nivo-plus-ipilimumab-ipi-vs-lenvatinib-len-or-sorafenib-sor-as-first-line-1l-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surrogacy-between-pathological-complete-response-and-overall-survival-an-individual-patient-data-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-botensilimab-bot-with-or-without-balstilimab-bal-for-patients-with-resectable-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-observational-study-of-chemotherapy-in-elderly-patients-with-biliary-trac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-retrospective-study-of-salvage-surgery-for-patients-with-residual-or-recurrent-esophag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-visceral-adipose-tissue-radiodensity-and-overall-survival-among-older-adults-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-disparities-in-allograft-access-in-the-era-of-post-transplant-cyclophosphamide-based-misma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/claudin-182-determination-in-locally-advanced-gastric-and-gastroesophageal-adenocarcinoma-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-protein-energy-malnutrition-on-clinical-outcomes-in-hospitalized-gastric-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tetravalent-death-receptor-5-dr5-agonist-ozekibart-inbrx-109-folfiri-in-2l-colorectal-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-candidate-biomarkers-for-gastric-cancer-by-bioinformatics-analysis-of-pooled-micro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-of-allostim-in-situ-cancer-vaccine-immunotherapy-as-3l-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-clinical-benefits-of-anti-cancer-drugs-approved-by-food-and-drug-administration-for-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-insurance-status-on-mortality-following-surgical-treatment-of-colorectal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-intravenous-pembrolizumab-and-intratumorally-injected-autologous-dendritic-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-plus-mfolfox6folfiri-sequential-bevacizumab-plus-capecitabine-maintenance-in-ras-mutate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-body-fat-and-ai-ensemble-technique-and-the-influence-on-false-positive-rate-in-ai-second-obs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-multi-site-translational-study-investigating-the-association-of-gut-microbiome-gm-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-of-radiofrequency-ablation-in-elderly-hepatocellular-carcinoma-patients-over-80-yea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-imeti-genomic-alterations-in-colorectal-cancer-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-of-lynch-syndrome-and-associated-clinicopathologic-features-in-patients-with-mismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-genomic-testing-performance-in-colorectal-cancer-crc-the-multiteam-systems-framework-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-analysis-of-pathological-complete-response-after-neoadjuvant-therapy-for-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-single-center-open-label-dose-de-escalation-and-expansion-study-of-ivosidenib-mfolfir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tas102-in-combination-with-oxaliplatin-tasox-for-refractory-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-rural-vs-urban-colon-cancer-mortality-in-texas-a-seer-database-analysis-from-201 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-time-to-surgery-on-outcomes-in-patients-with-advanced-esophageal-squamous-cell-carcinoma-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-exercise-in-gastric-cancer-patients-undergoing-gastrectomy-a-randomized-controlled-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-relapse-based-on-the-molecular-profiling-of-japanese-patients-with-stage-ii-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-delivery-and-biomarker-testing-for-people-with-colorectal-cancer-receiving-4r-care-sequence-pla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-12-study-mychelangelo-i-of-first-in-class-epigenomic-controller-otx-2002-tar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-glecirasib-jab-21822-monotherapy-and-in-combination-with-cetuximab-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-chemotherapy-with-fluorouracil-leucovorin-oxaliplatin-and-docetaxel-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcome-after-complete-response-with-immunotherapy-in-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-and-surgical-conversion-following-immunotherapy-in-msi-h-biliary-tract-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lapis-randomized-phase-3-trial-of-chemotherapy-ctx-with-and-without-pamrevlumab-pam-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anthracyclines-in-early-breast-cancer-the-long-goodbye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/goblet-platform-study-preliminary-safety-and-tumor-response-results-for-the-relapsed-anal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-detection-of-molecular-residual-disease-mrd-in-patients-pts-with-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-a-low-cost-minimally-invasive-screening-test-for-dihydropyrimidine-dehydrogenase-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-randomized-phase-ii-study-of-osimertinib-with-and-without-ramucirumab-in-ty 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-with-folfox-plus-bevacizumab-and-short-course-radiotherapy-for-ras-mutant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-first-line-nivolumab-plus-chemotherapy-for-her2-negative-advanced-gastric-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/positive-homologous-recombination-signature-hrdsig-and-the-genomic-landscape-of-intrahepatic-chol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-time-to-first-therapy-ttft-variable-on-survival-outcomes-of-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-prognostic-model-for-advanced-gastric-and-oesophageal-carcinoma-ago 2026-08-24 monthly 0.7 https://rjrindex.com/articles/costs-of-generic-vs-branded-nab-paclitaxel-np-during-first-line-1l-treatment-of-metastatic-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-short-term-efficacy-of-induction-dcf-plus-nivolumab-therapy-in-patients-with-unresect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-clinical-value-and-barriers-to-use-of-new-investigational-targeted-agents-in-the-commu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-racial-disparities-in-social-determinants-of-health-among-patients-with-gi-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expression-of-trop2-nectin-4-and-folr1-cell-surface-markers-in-biliary-tract-cancers-is-it-time-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/galeterone-monotherapy-in-advanced-pancreatic-ductal-adenocarcinoma-results-from-a-phase-two-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-atezolizumab-plus-bevacizumab-a-b-in-hispanic-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-immune-based-score-and-its-immune-contexture-exploration-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alternative-dosing-regimens-of-tislelizumab-proposed-using-modeling-and-simulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-study-of-the-homologous-recombination-deficiency-signature-hrdsig-status-of-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/universal-screening-for-mismatch-repair-deficiency-in-gastrointestinal-cancers-in-a-reference-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-disparities-in-small-intestine-carcinoid-tumors-a-seer-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-experiences-and-decision-making-among-patients-with-metastatic-colorectal-cancer-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/goblet-study-results-of-the-safety-run-in-for-first-line-metastatic-pancreatic-ductal-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-observational-study-to-evaluate-the-efficacy-of-trifluridinetipiracil-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/q-twist-analysis-of-pembrolizumab-plus-trastuzumab-and-chemotherapy-for-patients-with-metastatic-her 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-feasibility-safety-and-tumor-control-in-two-first-in-human-trials-of-a-novel-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-cabozantinib-and-nivolumab-in-refractory-metastatic-microsatellite-stable-mss-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/statistical-perspectives-and-meta-analytic-approaches-in-surrogate-end-point-evaluation-for-chronic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-a-phase-2-study-of-fruquintinib-plus-trifluridinetipiracil-tas-102-as-third-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-intraperitoneal-paclitaxel-in-eosinophil-activation-and-recruitment-in-the-peritoneal-cavity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-status-and-treatment-outcomes-of-intraductal-papillary-mucinous-carcinoma-in-korea-a-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-peritoneal-recurrence-following-laparoscopic-versus-open-surgery-for-stage-ii-or-iii-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-pathological-response-versus-recist-assessment-in-predicting-relapse-free-survival-following 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-and-long-term-outcomes-of-conversion-surgery-for-initially-unresectable-advanced-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-changes-in-body-composition-following-endoscopic-submucosal-dissection-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/birth-cohort-effects-in-appendiceal-adenocarcinoma-incidence-across-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-combined-with-penpulimab-and-nab-paclitaxel-as-first-line-treatment-for-advanced-esophagea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-with-ipilimumab-and-nivolumab-in-rectal-cancer-chinorec-a-prospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-profiling-of-gastroenteropancreatic-gep-neuroendocrine-tumors-nets-an-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-irasbrafi-and-ipik3cai-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mdm2-amplification-in-patients-with-biliary-tract-cancer-in-retud-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-multicenter-open-label-study-of-allostim-combined-with-anti-pd-l1immunotherapy-as-4l-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-treatment-patterns-and-clinical-outcomes-of-patients-treated-with-sequential-regoraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-short-term-efficacy-of-neoadjuvant-chemotherapy-in-elderly-patients-with-resectable-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-and-gemcitabine-based-chemotherapy-combined-with-or-without-lenvat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-liquid-biopsy-analysis-of-exosomal-mirna-to-detect-lymph-node-metastasis-in-early-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-residual-tumor-following-removal-of-a-malignant-colorectal-polyp-with-high-risk-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-socioeconomic-and-clinical-factors-contributing-to-treatment-delay-in-earl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-an-alteration-of-the-gut-microbiome-increase-risk-of-gastrointestinal-malignancies-insights-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-in-unresectable-or-metastatic-grade-3-pancreatic-neuroendocrine-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-for-a-colorectal-cancer-detection-blood-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-positivity-on-prognosis-and-targeted-therapeutic-outcomes-in-advanced-biliary-tract-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-tissue-modified-viral-ttmv-hpv-dna-as-a-biomarker-of-treatment-efficacy-for-definitive-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-2-study-of-triplet-blockade-of-the-il-27-pd-l1-and-vegf-pathways-with-casdo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-multicenter-randomized-phase-iii-trial-science-comparing-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-selection-for-advanced-or-metastatic-pancreatic-cancer-using-machine-learning-models-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-long-term-outcomes-for-neoadjuvant-chemoradiation-na-crt-followed-by-surgery-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-targeted-therapies-and-local-interventions-in-braf-v600e-mutated-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prediabetes-on-cerebrovascular-risk-among-patients-with-gastrointestinal-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-the-prognostic-value-of-early-induction-of-s-1-postoperative-adjuvant-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-mucin-5ac-muc5ac-as-a-predictor-of-outcomes-and-microscopic-distant-metastasis-in-pancreatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tisle-combined-with-pofi-irinotecan-paclitaxel-oxaliplatin-and-5-fulevoleucovorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-and-other-outcomes-of-hospitalizations-due-to-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-molecular-and-clinical-study-of-patients-with-young-onset-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-artificial-intelligence-in-colorectal-cancer-and-polyp-detection-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-5-fluorouracil-leucovorin-bevacizumab-as-second-line-therapy-in-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-ni-in-patients-pts-with-pancreatic-cancer-pc-with-ibr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-method-for-classifying-colorectal-cancer-and-gastricesophageal-cancer-using-blood-based-testing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-dose-adjustments-on-overall-survival-os-in-patients-with-metastatic-pancreatic-ductal-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acquired-gene-alterations-potentially-related-to-resistance-to-anti-her2-therapy-in-her2-positive-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-csf1r-as-a-potential-prognostic-biomarker-in-colorectal-cancer-alliance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relative-treatment-efficacy-of-cd40-agonist-mitazalimab-in-combination-with-mfolfirin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-secondary-metastasis-in-patients-with-hepatocellular-carcinoma-a-5-year-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-results-of-askb589-combined-with-capox-and-pd-1-inhibitor-as-first-line-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-study-of-jmt101-in-combination-with-irinotecan-and-sg001-versus-regorafenib-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-marker-of-recurrence-risk-in-stage-iii-colorectal-cancer-the-a-correct-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-clinical-trial-design-to-mitigate-racial-disparities-in-pancreatic-cancer-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-and-vemurafenib-plus-liposomal-irinotecan-ii-leucovorin-and-fluorouracil-for-braf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-tumor-shrinkage-with-survival-in-patients-with-her2-positive-advanced-gastric-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/more-isnt-always-better-expanding-and-refining-prognostic-methylation-signatures-for-pancreatic-du 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-tumoral-collagen-width-with-overall-survival-and-tumoral-collagen-straightness-with-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilizing-an-automated-high-throughput-platform-to-generate-comprehensive-clinical-amp-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-stereotactic-radiotherapy-in-brain-metastases-from-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-mutations-and-cytotoxic-chemotherapy-response-for-advanced-solid-tumors-a-detailed-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-in-borderline-resectable-and-resectable-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-comparative-study-on-real-world-clinical-and-genomic-differences-in-advanced-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-disease-aetiology-on-outcomes-for-unresectable-hcc-treated-with-lenvatanib-or-atezobev-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-study-of-clinical-and-molecular-features-in-patients-with-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-large-scale-pdo-based-assays-to-optimize-antibody-drug-conjugate-efficacy-in-crc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-prospective-study-to-evaluate-the-efficacy-of-resection-for-initially-unresectable-hep-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everest-2-a-seamless-phase-12-study-of-a2b694-a-logic-gated-tmod-chimeric-antigen-receptor-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-skeletal-muscle-morphometrics-and-overall-survival-among-older-adults-with-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-osimertinib-and-vascular-endothelial-growth-factor-receptor-inhibitors-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-different-total-neoadjuvant-therapy-strategies-in-patients-with-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-trastuzumab-deruxtecan-t-dxd-54-mgkg-triplet-combination-of-destiny-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-of-early-onset-colorectal-cancer-eocrc-in-the-united-states-by-age-sex-race-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exclusive-liver-invasion-as-prognostic-indicator-in-t3-gallbladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-using-neoadjuvant-rectal-score-in-patients-with-locally-advanced-rectal-cancer-who 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-pancreatic-cancer-hospitalizations-a-ten-year-trend-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-literature-review-slr-of-prognostic-factors-pfs-in-locally-advanced-rectal-cancer-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-clinical-and-molecular-characteristics-of-class-ii-and-iii-braf-mutations-and-thei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-internal-radiation-therapy-with-yttrium-90-resin-microspheres-followed-by-lenvatinib-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/q-twist-analysis-of-pembrolizumab-or-placebo-plus-chemotherapy-for-patients-with-advanced-her2-negat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-expression-in-small-bowel-adenocarcinoma-a-potential-target-for-novel-therapeutic-strategies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-neuroendocrine-tumors-in-the-historically-underserved-population-of-bronx-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-variation-in-trajectories-of-colon-cancer-mortality-2012-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-subgroup-analysis-of-first-line-serplulimab-plus-bevacizumab-and-xelox-versus-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-impact-of-lymph-node-ratio-on-survival-in-patients-with-pancreatic-cancer-undergoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-surgery-and-overall-survival-in-non-metastatic-anal-cancer-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sil-204-sirna-encapsulated-in-extended-release-microparticles-for-the-treatment-of-localized-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-xl092-alone-or-in-combination-with-atezolizumab-in-patients-pts-with-refractory-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-iparomlimab-and-tuvonralimab-ql1706-or-iparomlimab-ql1604-bevacizumab-bev-for-unr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-dose-escalation-trial-of-gemcitabine-and-nab-paclitaxel-in-combination-with-lixumistat-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-in-patients-with-ibrcai-mutated-unresectable-or-recurrent-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-docetaxel-and-cyclophosphamide-with-or-without-epirubicin-for-early-breast-cancer-final-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-cfdna-and-dna-integrity-index-dii-in-colon-cancer-in-response-to-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-or-chemo-radiation-in-gallbladder-cancer-a-phase-iii-randomized-controlled-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-adjuvant-chemoradiotherapy-in-pancreatic-adenocarcinoma-with-r1-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/moonray-01-a-phase-1-study-of-ly3962673-a-potent-orally-bioavailable-and-selective-kras-g12d-inh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-intraperitoneal-ip-mesothelin-msln-targeted-car-t-cell-therapy-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxel-oral-solution-versus-paclitaxel-injection-as-a-second-line-therapy-in-advanced-gastric-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-next-generation-sequencing-in-advanced-gastrointestinal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tyra-430-first-reversible-fgfr43-inhibitor-designed-to-overcome-current-challenges-in-fgf19-driven 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-tis-chemotherapy-chemo-vs-placebo-pbo-chemo-as-first-line-1l-treatment-in-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kirros-a-phase-ii-trial-in-progress-of-first-line-atezolizumab-atezo-with-or-without-bevacizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physical-activity-and-sedentary-behavior-patterns-after-early-onset-colorectal-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-gastric-cancer-patients-with-positive-peritoneal-cytology-who-underwent-upfro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-fluoropyrimidine-chemotherapy-dosing-and-toxicity-in-patients-with-screen-det 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-neoadjuvant-nalirifox-followed-by-chemoradiation-with-paclitaxel-and-carboplatin-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alteration-of-gut-microbiota-in-patients-with-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/encorafenib-and-cetuximab-withwithout-binimetinib-therapies-for-patients-with-ibraf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-pd-1-inhibitors-and-chemotherapy-in-the-first-line-treatment-of-her2-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-methods-evaluation-of-the-canopy-cancer-collectives-implementation-of-network-wide-screenin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-from-radical-esophagectomy-to-definitive-chemoradiotherapy-after-neoadjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-phase-ii-trial-of-low-dose-decitabine-and-sintilimab-combined-with-chemotherapy-in-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-malnutrition-at-diagnosis-with-survival-among-older-adults-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-20-year-population-wide-cohort-study-on-association-of-aspirin-and-risk-of-gastrointestinal-and-no 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-preoperative-treatment-strategy-for-conversion-surgery-in-unresectable-locally-advanced-panc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-the-her3-directed-antibody-drug-conjugate-patritumab-deruxtecan-mk-1022-as-mono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-neoadjuvant-therapy-followed-by-total-mesorectal-excision-and-selective-lateral-lymph-node-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-multi-target-stool-dna-test-in-the-us-asian-population-from-2017-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-methylation-based-tissue-agnostic-test-for-the-detection-of-molecular-residual-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-mortality-and-financial-burdens-in-patients-with-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-interval-circulating-tumor-dna-ctdna-kinetics-as-a-predictor-of-tumor-response-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-olaparib-in-patients-with-advanced-pancreatic-acinar-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-irasi-and-ibrafi-heterogeneity-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-pts-with-metastatic-colorectal-cancer-mcrc-who-received 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distribution-of-lymph-node-metastasis-and-prognosis-in-duodenal-bulb-tumors-a-multicenter-retrospec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-gene-expression-profiling-to-examine-association-between-muc1-and-claudin-18-in-gastrointesti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncomine-panel-testing-in-the-clinical-management-of-colorectal-cancer-an-irish-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-a-multicenter-retrospective-cohort-study-evaluating-the-safety-and-efficacy-of-ftdtpi-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hcc-in-the-rio-grande-valley-outcomes-in-a-predominant-latino-community 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-endoscopic-retrograde-cholangiopancreatography-ercp-vs-percutaneous-transhe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-healthcare-resource-utilization-hcru-and-costs-in-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-predictors-of-multi-target-stool-dna-test-completion-in-an-underserved-primary-care-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-long-term-chemotherapy-ctx-on-outcomes-in-pancreatic-ductal-adenocarcinoma-pdac-a-rea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adherence-to-the-2018-world-cancer-research-fundamerican-institute-for-cancer-research-wcrfaicr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-features-of-the-morphological-subtypes-in-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agitg-spar-a-randomized-placebo-controlled-phase-ii-trial-of-simvastatin-in-addition-to-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/young-onset-gastrointestinal-cancer-a-needs-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-insights-into-immune-related-adverse-events-irae-in-gastrointestinal-gi-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-cancer-related-deaths-in-patients-with-resectable-locally-advanced-esophageal-squamous-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalised-use-of-repurposed-non-anticancer-drugs-in-colorectal-cancer-based-on-up-regulated-signa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-analysis-of-first-line-encorafenib-cetuximab-chemotherapy-in-braf-v600e-mutant-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-of-combination-therapy-with-everolimus-plus-lanreotide-versus-everolimus-monothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-antitumor-activity-and-circulating-tumor-dna-ctdna-changes-with-rmc-9805-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/refining-colorectal-cancer-screening-strategies-using-polygenic-risk-scores-and-classical-risk-facto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-immunotherapy-for-real-world-patients-with-her2-negative-advanced-gastric-cancer-between 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u06-phase-12-umbrella-platform-study-of-trop2-antibody-drug-conjugate-sacituzumab-tirumot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-gut-microbiota-profiles-among-normal-colorectal-mucosa-adenomatous-and-hyperplastic-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-and-prognostic-impact-of-ignasi-mutations-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-lysis-syndrome-in-colorectal-cancer-a-systematic-review-of-clinical-characteristics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-best-supportive-care-for-patients-with-metastatic-colorectal-cancer-characterizat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjvuant-chemotherapy-versus-chemoradiation-for-esophageal-adenocarcinoma-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-cabozantinib-alone-or-in-combination-with-panitumumab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-of-circulating-tumor-dna-ctdna-tumor-fraction-with-prognosis-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-of-immunotherapy-with-ex-vivo-pre-activated-and-expanded-cbnk-cells-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-synergistic-effects-in-trials-of-combination-therapies-with-immune-checkpoint-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-pharmacogenetic-testing-in-the-management-of-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-pd-l1-cps-and-clinical-outcomes-in-patients-treated-with-first-line-nivolumab-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-intraperitoneal-paclitaxel-based-regimens-in-patients-with-gastric-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agx101-a-tm4sf1-directed-tubulin-inhibitor-conjugate-in-ongoing-first-in-human-trial-including-gi-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-formulated-favezelimab-plus-pembrolizumab-versus-standard-of-care-in-previously-treated-pd-l1-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-in-combination-with-lenvatinib-and-albumin-paclitaxel-for-previously-treated-advanced-ge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optical-coherence-tomography-and-elastography-for-the-visualization-of-architecture-and-stiffness-di 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-colorectal-cancer-screening-using-medicare-centers-for-medicare-and-medicaid-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-result-of-a-phase-ib-study-efficacy-and-safety-of-fg-m108-plus-gemcitabinenab-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-for-predicting-complete-response-to-total-neoadjuvant-therapy-in-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraperitoneal-and-intravenous-paclitaxel-plus-s-1-versus-intravenous-paclitaxel-plus-s-1-in-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-tumor-immune-microenvironment-time-and-somatic-landscape-in-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thoracic-radiotherapy-improves-the-survival-in-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-relevance-of-tumor-fraction-assessment-from-circulating-tumor-dna-in-metastatic-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-for-progression-free-survival-in-patients-with-locally-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-adjuvant-component-of-perioperative-chemotherapy-and-survival-outcomes-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-anti-epidermal-growth-factor-receptor-agents-in-elderly-patients-age-70-years-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muc5ac-levels-as-predictors-of-adjuvant-therapy-outcomes-in-pancreatic-ductal-adenocarcinoma-a-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-for-patients-with-neoadjuvant-treatment-between-2019-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-icis-in-deficient-mismatch-repair-dmmrmicrosatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-adebrelimab-combined-with-chemotherapy-for-locally-advanced-resectable-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpatient-palliative-care-on-end-of-life-care-among-patients-with-early-onset-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mek-inhibitor-based-therapy-in-metastatic-pancreatic-adenocarcinoma-with-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-demographic-disparities-and-survival-outcomes-of-gastrointestinal-malignancies-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dose-escalated-radiation-for-locally-advanced-unresectable-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/challenges-in-patient-selection-for-surgical-options-in-v600e-braf-mutated-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/current-status-of-physicians-perception-of-hcc-conversiondownstaging-therapy-a-nationwide-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diverse-stromal-phenotypes-at-spatial-resolution-in-colorectal-cancer-peritoneal-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-communication-barriers-impacting-postoperative-decision-regret-in-patients-with-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-molecular-characteristics-of-patients-with-locoregional-ampullary-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nimotuzumab-combined-with-chemotherapy-plus-immunotherapy-as-first-line-treatment-for-advanced-esoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serial-monitoring-of-circulating-tumor-dna-as-a-marker-of-response-to-immune-checkpoint-blockade-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-y220c-mutations-in-colorectal-carcinoma-crc-a-genomic-landscape-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-protein-based-blood-panel-test-for-the-early-detection-of-colorectal-cancer-and-advanced-neoplasia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-oncopig-hepatocellular-carcinoma-model-an-innovative-large-animal-platform-for-evaluating-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-agent-olaparib-in-advanced-oesophago-gastric-cancer-primary-results-from-the-solar-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-organ-preserving-strategy-in-patients-with-esophageal-squamous-cell-carcinoma-treated-with-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ck2-expression-gastrointestinal-cancer-exploring-clinical-characteristics-and-cancer-genetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-a-phase-ii-study-of-acalabrutinib-venetoclax-and-obinutuzumab-avo-in-a-treatment-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-preoperative-pembrolizumab-for-msi-high-or-msspd-l1-gastric-cancer-followed-by-surgery-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-camrelizumab-rivoceranib-vs-sorafenib-cares-310-as-first-line-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-following-complete-clinical-response-to-chemoradiotherapy-for-rectal-cancer-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unitepanc-using-organoids-to-predict-efficacy-of-adjuvant-treatment-to-improve-outcome-in-resectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanded-biomarker-analysis-of-an-international-open-label-phase-2-study-of-regorafenib-plus-pembro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-medicine-and-multidisciplinary-care-in-gastric-and-gastroesophageal-junction-ggej-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-by-transarterial-chemoembolization-tace-modality-from-participants-pts-with-embolizatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-aspirin-to-reduce-recurrence-rate-in-colorectal-cancer-patients-with-pi3k-pathway-alteratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-plus-benmelstobart-as-adjuvant-therapy-in-patients-with-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-and-risk-factors-for-recurrence-of-hepatocellular-carcinoma-after-initial-complete-remission-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-validation-of-the-khorana-risk-score-in-gastric-cancer-patients-receiving-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-the-use-of-a-first-line-folfirinox-like-regimen-in-older-patients-with-metastatic-pancrea-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-prospective-analysis-of-the-relationship-between-nanoliposomal-irinotecan-and-fluoroura 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seven-year-efficacy-and-safety-in-a-randomized-phase-iii-trial-investigating-duration-of-adjuvant-ox 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-computed-tomography-ct-based-staging-of-mismatch-repair-deficient-dmmr-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-adherence-in-average-risk-african-americans-from-2017-2024 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-neratinib-nera-in-combination-with-chemotherapytrastuzumabpembrolizumab-ct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adherence-to-nccn-and-bclc-treatment-guidelines-on-survival-in-hcc-a-single-center-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cetuximab-every-second-week-in-combination-with-daily-encorafenib-in-patients-with-braf-v600e-mutate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-colorectal-cancer-ct-imaging-features-involving-microsatellite-instability 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-eol-outcomes-and-healthcare-utilization-for-patients-with-hepatocellular-carcinoma-hc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nelmastobart-hstc810-combined-with-capecitabine-therapy-in-metastatic-colorectal-cancer-with-resis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-and-outcomes-of-patients-with-brafv600e-mutant-metastatic-colorectal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-safety-trial-of-antibiotic-fecal-microbiota-transplantation-for-esophageal-and-gastric-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nirogacestat-in-patients-with-desmoid-tumors-and-mutations-of-adenomatous-polyposis-coli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-sequential-petct-imaging-to-predict-complete-response-after-definitive-chemoradiotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immune-checkpoint-inhibitors-in-patients-with-advanced-pancreatic-nets-displaying-high-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-local-therapy-in-solitary-liver-metastatic-anal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-preliminary-efficacy-of-atg-022-in-patients-with-advancedmetastatic-gastric-cancer-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-immunotherapy-for-advanced-melanoma-how-to-choose 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-retrospective-study-evaluating-mitomycin-dosing-during-chemoradiation-in-anal-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-nucleotyping-and-tumor-stroma-ratio-to-predict-prognosis-in-patients-with-resected-intestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-trf-28-zj47d112z4dz-on-the-pathogenesis-of-gastric-cancer-through-targeting-cyclin-d1cdk4 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-of-radiotherapy-combined-with-tegafur-bolus-synchronization-in-the-treatment-of-inope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-trifluridinetipiracil-tas-102-plus-irinotecan-in-combination-with-bevacizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-adebrelimab-plus-chemotherapy-for-resectable-locally-advanced-esophageal-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-blockade-in-resectable-hepatocellular-carcinoma-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-immunogenomic-landscape-of-primary-and-metastatic-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-2-2-5-5-model-for-stratifying-liver-metastasis-burden-in-patients-with-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-in-digestive-tumors-with-mismatch-repair-deficiency-or-microsatellite-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-care-disparities-in-an-urban-diverse-population-a-tale-of-two-hospitals-in-the-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-neoadjuvant-chemotherapy-followed-by-surgery-and-definitive-chemoradiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-early-onset-versus-average-onset-gastroesophageal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-hypofractionated-radiotherapy-5x5-gy-with-a-simultaneous-integrated-boost-5x 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-restricted-mean-survival-time-rmst-analysis-of-survival-in-advanced-hepatocellular-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-shr-1701-a-bifunctional-anti-pd-l1tgf-vrii-agent-combined-with-chemoradiotherapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-in-physical-cognitive-and-sexual-health-in-early-onset-gastrointestinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-phase-ibii-study-of-fruquintinib-combined-with-sox-and-toripalimab-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-socioeconomic-disparities-in-cancer-free-and-all-cause-survival-in-cholangiocarcinoma-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-amplification-ratio-for-established-and-emerging-biomarkers-in-gastroesophageal-ge-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cabozantinib-for-advanced-gastrointestinal-gi-neuroendocrine-tumors-net-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-molecular-residual-disease-mrd-testing-with-measurement-of-circulating-tumor-dna-ctdna-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-alter-h004-study-anlotinib-combined-with-tace-as-adjuvant-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-institutional-retrospective-study-evaluating-clinical-outcomes-and-prognostic-factors-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-the-randomized-trial-on-open-versus-laparoscopic-surgery-for-primary-tumor-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soxfolfoxnivolumab-followed-by-conversion-surgery-for-her2-negative-primary-gastric-or-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-postoperative-complications-after-neoadjuvant-therapy-followed-by-esophagectomy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-anlotinib-as-a-later-line-treatment-for-advanced-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-impact-of-a-genome-wide-homologous-recombination-deficiency-signature-hrdsig-on-the-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-total-neoadjuvant-treatment-tnt-for-locally-advanced-rectal-cancer-maria-sk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-metastatic-dmmr-immunotherapy-commit-study-a-randomized-phase-iii-study-of-atez-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-variants-and-clinical-factors-affecting-the-response-to-5-fluorouracil-based-treatment-in-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-expression-of-metabolic-genes-on-patient-pts-outcomes-in-metastatic-colorectal-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-incidence-and-mortality-of-colorectal-cancer-in-appalachian-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-presenting-symptoms-of-patients-with-appendiceal-malignant-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-adherence-among-average-risk-45-to-49-year-old-patients-from-2017-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-biomarker-testing-patterns-first-line-treatment-and-drivers-of-treatment-choice-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-homologous-recombination-deficiency-on-survival-and-chemotherapy-response-in-small-bowel-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-peri-operative-novottf-200tp-in-combination-with-gemcitabine-and-nab-paclitaxe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-effect-of-the-gut-microbiome-on-tumour-response-to-anti-cancer-treatment-in-patients-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/highly-accurate-detection-of-early-stage-colorectal-cancer-using-tumor-and-immune-extracellular-vesi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-based-total-neoadjuvant-therapy-combined-with-tislelizumab-in-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-changes-in-body-composition-and-sociodemographic-factors-on-colon-cancer-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-microscopic-residual-disease-mrd-monitoring-with-circulating-tumor-dna-ctdna-in-pancr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amber-part-2f-cobolimab-in-combination-with-dostarlimab-in-treatment-naive-patients-with-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-metastatic-gastric-cancer-gc-in-patients-aged-80-years-or-older-immediate-and-long-term-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concordance-between-human-epidermal-growth-factor-receptor-2-her2-status-by-immunohistochemistry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-associated-with-metastatic-early-onset-colorectal-cancer-among-black-patients-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/valemetostat-and-trastuzumab-deruxtecan-t-dxd-in-previously-treated-advanced-or-metastatic-human-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-features-of-epstein-barr-virus-associated-gastric-cancer-based-on-pd-l1-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-biological-divergence-of-upper-gastrointestinal-adenocarcinomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-ethnic-disparities-in-hepatocellular-carcinoma-trends-in-incidence-rates-across-us-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-chemotherapy-regimen-matter-for-first-line-immunochemotherapy-in-low-programmed-cell-death-liga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-among-us-adults-with-unresectable-hepatocellular-carcinoma-uhcc-el 2026-08-24 monthly 0.7 https://rjrindex.com/articles/xpo1-inhibition-as-a-clinically-viable-strategy-to-enhance-durability-of-response-to-kras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-evaluating-the-genomic-landscape-of-anal-squamous-cell-carcinoma-using-liquid-bi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-target-stool-dna-test-for-colorectal-cancer-screening-and-effects-on-health-and-economic-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-analysis-of-medicare-expenditure-and-utilization-of-egfr-inhibitors-from-2018-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pd-1-inhibitor-plus-chemotherapy-versus-chemotherapy-in-advanced-esophageal-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-risk-stratification-in-older-intensively-treated-patients-with-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-portion-of-the-action-1-phase-1b3-trial-of-ryz101-in-gastroenteropancreatic-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intra-arterial-gemcitabine-versus-intravenous-gemcitabine-pharmacokinetic-sub-study-of-the-tiger-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-the-alter-e009-study-efficacy-and-safety-of-anlotinib-combined-with-radiothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conversion-effects-of-pd-1-inhibitor-camrelizumab-cam-combined-with-nab-pof-regimen-in-patients-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-determinants-of-targeted-therapy-tt-outcomes-in-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-combined-with-folfirimfolfox6-as-second-line-treatment-in-patients-with-ras-mutant-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiationscrt-followed-by-6-cycles-of-cadonilimab-plus-mfolfox6-as-neoadjuvant-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-open-label-first-in-human-study-of-tyra-200-in-advanced-intrahepatic-cholangiocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-for-thermo-ablation-of-liver-metastases-in-colon-cancer-a-maltese-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-genomic-profiles-and-survival-outcomes-in-patients-with-her2-positive-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-site-blinded-validation-of-a-deep-learning-approach-for-clinical-grade-msidmmr-detection-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-analysis-and-clinical-validation-to-identify-biomarkers-for-trifluridinetipiracil-ftd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-of-surveillance-ct-scan-ordering-in-patients-with-stage-iiiii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-tas-102-and-chemotherapy-rechallenge-in-the-third-line-setting-and-beyond-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/observational-study-of-the-extent-of-lymph-node-metastasis-among-patients-who-underwent-pancreatoduo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-benefits-of-asymptomatic-primary-tumor-resection-after-bevacizumab-plus-folfiri-as-first-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-protocol-for-pretreatment-testing-for-antibodies-to-galactose-alpha-13-galactose-to-mitigate-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-immune-related-adverse-events-and-prognosis-after-immune-checkpoint-inhibitor-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-with-either-s-1-or-5-fluorouracil-plus-oxaliplatin-and-docetaxel-for-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-combined-resection-of-pancreas-on-long-term-survival-in-patients-with-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extra-hepatic-ehcca-and-intra-hepatic-cholangiocarcinomas-icca-a-genomic-landscape-comparison-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equity-gi-a-prospective-study-to-enhance-quality-inclusivity-and-trial-participation-in-black-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-assess-the-safety-and-efficacy-of-flx475-tivumecirnon-combined-with-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-and-therapeutic-impact-of-tumor-mutational-burden-in-microsatellite-instabilitymismatch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-fruquintinib-plus-sintilimab-as-a-second-line-therapy-for-advanced-gastric-and-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-nutritional-status-in-elderly-patients-with-gastroesophageal-cancer-a-post-hoc-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-prognostic-significance-of-ikras-g12ci-mutation-in-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characteristics-of-high-risk-recurrent-or-metastatic-endometrial-cancer-tha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transarterial-chemoembolization-tace-combined-with-camrelizumab-and-apatinib-versus-tace-alone-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-crossover-of-the-bevacizumab-and-panitumumab-survival-curves-in-the-paradigm-study-a-clue-to-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/histopathological-growth-patterns-of-gastric-cancer-liver-metastasis-and-their-association-with-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-plus-camrelizumab-combined-with-paclitaxel-liposome-and-nedaplatin-as-first-line-treatm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-benmelstobart-plus-anlotinib-combined-with-sox-in-the-first-line-treatment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-trends-and-outcomes-of-appendiceal-cancers-a-national-cancer-database-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-cancer-among-patients-with-a-first-primary-appendiceal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-tab-eoao-study-trends-in-use-and-benefit-of-adjuvant-chemotherapy-between-early-onset-and-avera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-of-patients-with-early-onset-versus-average-onset-small-bowel-neuroendo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-predictive-factors-for-detecting-kras-mutations-in-pancreatic-cancer-using-liquid-biopsy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathologic-characteristics-in-young-patients-with-metastatic-colorectal-cancer-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inpatient-palliative-care-consultation-on-end-of-life-care-among-patients-with-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-impact-of-islfn11i-gene-expression-in-metastatic-colorec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ctdna-levels-timing-of-blood-collection-and-overall-survival-in-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-12-study-of-the-trophoblast-cell-surface-antigen-2-trop2-antibody-drug-conjugate-adc-saci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-value-of-para-aortic-lymph-node-dissection-in-gastric-cancer-with-extensive-lymph-node-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-versus-adjuvant-therapy-in-resectable-pancreas-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-atezolizumab-bevacizumab-atezobev-or-durvalumab-tremelimumab-durvatreme-in-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obesity-and-biliary-tract-cancers-changing-epidemiology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-proteinuria-with-atezolizumab-plus-bevacizumab-versus-lenvatinib-in-first-line-systemic-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-low-dose-regorafenib-with-pembrolizumab-for-patients-with-msi-h-colorectal-cancer-regpem-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-methylation-signature-for-gemcitabine-sensitivity-in-pancreatic-ductal-adenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cohort-level-patient-derived-organoid-assays-and-prediction-of-clinical-trial-outcomes-in-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-and-biomarker-analysis-of-the-efficacy-and-safety-of-pd-1-inhibitor-combined-with-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanidatamab-dose-optimization-in-patients-with-her2-positive-biliary-tract-cancer-btc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-chemotherapy-versus-placebo-plus-chemotherapy-in-patients-with-advanced-her2-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-of-cancer-biomarker-testing-results-what-patients-need 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-os-of-patients-with-metastatic-pancreatic-ductal-adenocarcinoma-mpdac-treated-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-ex-vivo-pharmacotyping-of-patient-derived-tumor-organoids-and-personalized-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-1203-gitc-innovation-integration-of-trastuzumab-t-with-or-without-pertuzumab-p-into-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-assessed-by-a-10-item-index-from-comprehensive-geriatric-assessment-fi-cga-10-versus-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-safety-of-immune-checkpoint-inhibitors-prior-to-liver-transplant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-randomized-phase-2-part-of-the-aspen-06-study-a-phase-23-study-of-evorpacept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-link-between-liver-cirrhosis-and-liver-metastasis-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-tolerability-and-preliminary-efficacy-of-tinodasertib-as-a-monotherapy-or-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-sup177sup-lu-dotatate-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-treatment-results-for-oligo-recurrence-of-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-the-real-world-first-line-1l-use-of-single-dose-tremelimumab-regular-interval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-conversion-therapy-for-metastatic-esophageal-cancer-exploratory-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-gastric-cancer-registry-a-multi-omic-cellular-and-molecular-resource-for-cancer-biomarker-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemoimmunotherapy-for-patients-with-gastric-or-gastroesophageal-junction-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-rates-of-attrition-and-barriers-to-surgical-resection-in-patients-undergoing-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-data-review-on-community-physicians-treatment-preferences-in-frontline-esophageal-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoradiotherapy-crt-followed-by-sequential-tislelizumab-tis-capox-and-tis-monotherapy-for-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-relationship-between-the-tumor-microenvironment-of-hepatocellular-carcinoma-and-apparent-diffusi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gpr120-and-ngf-with-perineural-invasion-in-cholangiocarcinoma-clinical-and-experimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-pdacai-v20-in-predicting-relative-benefit-from-frontline-folfirinox-ffx-and-gemcita 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-and-survival-in-anal-adenocarcinoma-a-seer-study-of-racial-and-age-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-literature-review-of-studies-assessing-first-line-1l-treatments-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-socioeconomic-disparities-and-the-likelihood-of-multimodal-treatment-utilization-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-legal-and-administrative-burden-support-collabs-a-pilot-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pd-1-blockade-in-mismatch-repair-deficient-or-microsatellite-instability-high-locally-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-development-of-the-lipid-nanoparticle-based-mrna-vaccine-with-multiple-natural-t-cell-ep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-outcomes-of-90-yttrium-radioembolization-in-combination-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-outcomes-for-early-and-late-drainage-of-malignant-ascites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-trial-of-encorafenib-cetuximab-and-nivolumab-in-microsatellite-stable-ibr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-immunotherapy-response-in-deficient-mismatch-repair-colorectal-cancers-using-an-immune 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-outcomes-for-metastatic-early-onset-small-bowel-adenocarcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-alterations-as-predictive-biomarkers-for-cancer-associated-thrombosis-cat-in-biliary-tract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peak-part-1-summary-a-phase-3-randomized-open-label-multicenter-clinical-study-of-bezuclastinib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mek-inhibitor-based-therapy-in-metastatic-pancreatic-adenocarcinoma-with-ikrasi-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-mortality-in-upper-gastrointestinal-tract-cancer-using-long-short-term-memory-neural-netw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-or-placebo-plus-chemotherapy-for-advanced-her2-negative-gastric-or-gastroesophageal-ju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-pathological-characteristics-follow-up-and-survival-of-patients-with-early-onset-vs-late 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-and-molecular-mechanism-of-gdf5-in-regulating-cell-migration-and-angiogenesis-via-the-hippo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-late-recurrence-of-colorectal-cancer-crc-among-older-long-term-survivors-using-claim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-combined-with-immunotherapy-and-prognosis-of-unresectable-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-bispecific-and-car-t-cell-therapies-in-gastric-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blood-tctp-as-a-biomarker-associated-with-immunosuppressive-features-and-resistance-to-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characterization-of-ifapi-and-ispp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prompt-initiation-of-durvalumab-and-tremelimumab-treatment-for-unresectable-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-adults-with-early-stage-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avutometinib-plus-cetuximab-after-chemotherapy-in-patients-with-ikrasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chidamide-plus-envafolimab-combined-with-s-1-as-second-line-treatment-in-advanced-and-metastatic-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-targeting-ctmp-on-immunogenicity-of-msi-l-colon-adenocarcinoma-cells-by-metabolism-and-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-extracolonic-malignancies-in-patients-with-familial-adenomatous-polyposis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zimberelimab-platform-study-safety-and-efficacy-of-zimberelimab-in-combination-with-futibatinib-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-excess-costs-associated-with-hematologic-adverse-events-haes-during-first-line-1l-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/p53-pathway-genes-mutations-as-prognostic-factors-in-patients-pts-with-metastatic-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-the-delay-of-surgery-in-localized-rectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-race-on-end-of-life-care-among-patients-with-esophageal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tinengotinib-in-patients-with-advanced-metastatic-cholangiocarcinoma-overall-survival-results-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-single-arm-single-center-clinical-trial-of-all-trans-retinoic-acid-bevacizumab-and-atezo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-results-of-a-phase-1-trial-evaluating-a-her2-directed-car-t-product-selective-for-the-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatocellular-carcinoma-a-30-year-trend-analysis-of-global-burden-stratified-by-risk-factors-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-first-line-sotorasib-panitumumab-and-folfiri-versus-folfiri-with-or-without-bev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-of-patients-with-liver-single-organ-metastases-updated-survival-results-of-bbcapx-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc1527jcog1609intesso02-diffusion-weighted-magnetic-resonance-imaging-dw-mri-assessment-of-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-survival-results-of-zl-irian-irinotecan-plus-anlotinib-or-in-combination-with-penpulimab-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-ras-mutation-result-availability-in-newly-diagnosed-patients-with-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-supportive-medications-to-prevent-and-manage-key-adverse-events-during-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-patients-with-locally-advanced-rectal-cancer-in-the-total-neoadjuvant-therapy-tnt-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-adjuvant-radiotherapy-after-endoscopic-resection-of-early-esophagus-cancer-to-prevent-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiological-characteristics-of-gastric-and-pancreatic-cancers-in-latin-america-gaspar-lacog-02 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-lipogenic-and-metabolic-subtypes-and-survival-outcome-in-patients-with-pancreatic-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proto-oncogene-hras-transcript-level-and-overall-survival-in-stage-ii-and-iii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fg-m108-plus-capecitabine-and-oxaliplatin-capox-for-first-line-treatment-of-cldn182her2-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-i-trial-with-antibody-drug-conjugate-adct-701-in-neuroendocrine-tumors-and-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-cross-sectional-analysis-from-a-real-world-cohort-of-patients-with-microsatellite-instability-colo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-randomized-study-evaluating-safety-efficacy-and-optimal-dose-of-abbv-400-in-combination-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/man-versus-machine-comparative-analysis-of-chatgpts-colon-cancer-guidance-and-expert-opinion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agitg-ascend-randomised-double-blind-phase-ii-study-of-certepetide-or-placebo-added-to-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-evaluate-chm-2101-an-autologous-cadherin-17-cdh17-chimeric-antigen-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-cytokine-induced-killer-cell-immunotherapy-in-hepatocellular-carcinoma-extended-follow-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrate-iia-phase-iii-study-regorafenib-for-refractory-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-in-advanced-hepatocellular-carcinoma-with-child-pugh-b-a-multicenter-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-on-treatment-circulating-tumor-dna-ctdna-changes-from-a-phase-1-study-of-rmc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-radiation-related-esophageal-stricture-from-endoscopic-dilation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-stage-of-diagnosis-of-colon-cancer-differences-by-hispanic-background-race-and-eth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-cancer-stage-at-diagnosis-among-older-adults-with-gastrointestinal-cancers-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-locally-advanced-unresectable-and-de-novo-metastatic-pancreatic-duct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-and-timing-of-decreased-adherence-to-s-1-in-postoperative-docetaxel-s-1-therapy-for-gastri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-immune-related-adverse-events-and-clinical-outcomes-in-patients-treated-with-fir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pembrolizumab-in-advanced-esophageal-carcinoma-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-shallow-whole-genome-sequencing-profiling-in-patients-with-i-ras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-phase-iiiii-randomized-controlled-trials-rcts-to-determine-the-incidence-of-hype 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-a-gastroesophageal-adenocarcinoma-gea-multicohort-using-next-generation-seq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-disease-characteristics-in-young-vs-older-adults-with-colorectal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-of-futibatinib-plus-pembrolizumab-in-patients-with-esophageal-carcinoma-evaluating-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dmmrmsi-tumour-occurrence-during-follow-up-of-patients-with-lynch-syndrome-treated-with-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-antibiotic-use-and-survival-among-patients-receiving-first-line-immunotherapy-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-frailty-index-mfi-5-as-a-prognostic-tool-of-mortality-complications-and-readmissions-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumour-free-ctdna-detection-as-a-decision-tool-to-support-organ-preservation-in-node-negative-rectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-allograft-access-in-the-era-of-post-transplant-cyclophosphamide-based-mismatched-unre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alterations-in-gut-microbiome-in-age-and-diet-induced-colorectal-cancer-crc-progression-in-a-prec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-experience-with-atezolizumab-bevacizumab-ab-for-the-treatment-of-unresectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-phase-ii-trial-of-trastuzumab-deruxtecan-in-patients-with-gastrooesophageal-adenocarcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-and-stereotactic-radiotherapy-combined-in-subjects-with-advanced-hcc-a-phase-ii-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-prior-nivolumab-use-on-the-efficacy-of-second-line-taxane-based-chemotherapy-in-advanced-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-homologous-recombination-deficiency-on-survival-in-patients-with-metastatic-colorectal-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adequate-racial-and-ethnic-representation-in-cancer-clinical-trial-enrollment-real-world-evidence-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-capecitabine-in-resected-biliary-tract-cancers-real-life-data-from-a-multicenter-study-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-ketorolac-on-serum-gdf-15-and-il-8-in-patients-with-pancreatic-cancer-with-cachexia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-trends-in-incidence-and-mortality-of-pancreatic-cancer-an-analysis-of-the-surveillance-epi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-and-safety-of-pd-1-and-pd-l1-antibodies-in-combination-with-hepatic-arterial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoimmunotherapy-plus-radiotherapy-in-advanced-esophageal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beamion-bcgc-1-a-phase-ibii-trial-of-the-her2-selective-tyrosine-kinase-inhibitor-tki-zongertini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-synchronous-vs-metachronous-primary-tumor-resection-on-prognosis-of-braf-v600e-mutant-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-pathologic-response-in-the-colorectal-cancer-cohort-of-the-imhotep-phase-ii-trial-of-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-the-spear-scoring-model-and-predicting-overall-survival-in-unresectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-landscape-of-cell-free-dna-alterations-in-patients-with-advanced-biliary-tract-cancer-treat 2026-08-24 monthly 0.7